$INSY Sunday January 14 For the coming week INSY
Post# of 212
(Total Views: 456)
Posted On: 01/14/2018 10:42:11 AM
$INSY Sunday January 14
For the coming week INSY looks to take back a few cents from the losses that occurred this past week.
Monday's start will be interesting. Volume has been exceptional for the past two weeks. To say incredibly HIGH may be an understatement. If huge numbers of shares are traded on Monday, the share price may continue to follow the recent pattern of extremely high volume lower share price. The previous low share price of around $5.00 allowed a lot of profit to be made by those who bought at $5 and sold close to $10. Ideally, this profit taking is over.
The coming week should be a cliff hanger. Everything about the company's future product development looks outstanding. Everything about the current product lines looks very good. Everything that is CURRENTLY occurring with respect to the company's Executive Management is just about perfect. The ONLY shadow that occurs on image of INSYS Therapeutics is PAST executives' and senior managers' future trips to the court house. This shadow may continue to drive the profit takers to jump every time the share price goes up $X.XX/share. Yes, the individual share holder may make a nice quick profit BUT the action prevents the even HIGHER share price that may have occurred down the road. Long Term Risk v. Immediate Reward: the conundrum all investors face.
For the coming week INSY looks to take back a few cents from the losses that occurred this past week.
Monday's start will be interesting. Volume has been exceptional for the past two weeks. To say incredibly HIGH may be an understatement. If huge numbers of shares are traded on Monday, the share price may continue to follow the recent pattern of extremely high volume lower share price. The previous low share price of around $5.00 allowed a lot of profit to be made by those who bought at $5 and sold close to $10. Ideally, this profit taking is over.
The coming week should be a cliff hanger. Everything about the company's future product development looks outstanding. Everything about the current product lines looks very good. Everything that is CURRENTLY occurring with respect to the company's Executive Management is just about perfect. The ONLY shadow that occurs on image of INSYS Therapeutics is PAST executives' and senior managers' future trips to the court house. This shadow may continue to drive the profit takers to jump every time the share price goes up $X.XX/share. Yes, the individual share holder may make a nice quick profit BUT the action prevents the even HIGHER share price that may have occurred down the road. Long Term Risk v. Immediate Reward: the conundrum all investors face.
(0)
(0)